Bariatric surgery and the gut-brain communication-The state of the art three years later

Nutrition

Volumn 26, Issue 10, 2010, Pages 925-931

  Diniz, Maria de Fátima Haueisen S ^a   Azeredo Passos, Valéria M ^a   Diniz, Marco Túlio C ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Bariatric surgery; Gut peptides; Gut brain axis; Obesity

Indexed keywords

GASTRIC INHIBITORY POLYPEPTIDE; GASTROINTESTINAL HORMONE; GASTROINTESTINAL POLYPEPTIDE; GHRELIN; GLUCAGON LIKE PEPTIDE 1; NEUROTENSIN; PANCREAS POLYPEPTIDE; PEPTIDE DERIVATIVE; PEPTIDE YY; PRONEUROTENSIN; UNCLASSIFIED DRUG;

APPETITE; BARIATRIC SURGERY; COMORBIDITY; DIABETES MELLITUS; ENERGY BALANCE; GLUCOSE METABOLISM; GLYCEMIC CONTROL; HUMAN; LONGITUDINAL STUDY; NEUROENDOCRINE SYSTEM; NEUROMODULATION; PRIORITY JOURNAL; PROTEIN MODIFICATION; REVIEW; SATIETY; SURGICAL TECHNIQUE;

APPETITE REGULATION; BARIATRIC SURGERY; DIABETES MELLITUS, TYPE 2; ENERGY METABOLISM; GASTRIC INHIBITORY POLYPEPTIDE; GASTROINTESTINAL HORMONES; GHRELIN; GLUCAGON-LIKE PEPTIDE 1; GLUCOSE; HOMEOSTASIS; HUMANS; OBESITY, MORBID; PEPTIDE HORMONES; PEPTIDE YY; SATIATION;

EID: 77957259389     PISSN: 08999007     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nut.2009.11.018     Document Type: Review

References (59)

1. Smith B.R., Schauer P., Nguyen N. Surgical approaches to the treatment of obesity: bariatric surgery. Endocrinol Metab Clin N Am 2008, 37:943-964.
2. Diniz M.F.H.S., Passos V.M.A., Diniz M.T.C. Gut-brain communication: how does it stand after bariatric surgery?. Curr Opin Clin Nutr Metab Care 2006, 9:629-636.
3. Van Der Lely A.J. Ghrelin and new netabolic frontiers. Horm Res 2009, 71(suppl 1):129-133.
4. Sundbom M., Holdstock C., Engström B.E., Karlssom F.A. Early changes in ghrelin following Roux-en-Y gastric bypass: influence of vagal nerve functionality?. Obes Surg 2007, 17:304-310.
5. Garcia-Fuentes E., Garrido-Sanchez L., Garcia-Almeida J.M., Garcia-Arnes J., Gallego-Perales J.L., Rivas-Marin J., et al. Different effect of laparoscopic Roux-en-Y gastric bypass and open biliopancreatic diversion of Scopinaro on serum PYY and ghrelin levels. Obes Surg 2008, 18:1424-1429.
6. Ybarra J., Bobbioni-Harsch E., Chassot G., Huber O., Ph Morel, Assimacopoulos-Jeannet F., et al. Persistent correlation of ghrelin plasma levels with body mass index both in stable weight conditions and during gastric-bypass-induced weight loss. Obes Surg 2009, 19:327-331.
7. Pardina E., López-Tejero M.D., Llamas R., Catalán R., Galard R., Allende H., et al. Ghrelin and apolipoprotein AIV levels show opposite trends to leptin levels during weight loss in morbidly obese patients. Obes Surg 2009, 19:1414-1423.
8. García de la Torre N., Rubio M.A., Bordiu E., Cabrerizo L., Aparicio E., Hernández C., et al. Effects of weight loss after bariatric surgery for morbid obesity on vascular endothelial growth factor-A, adipocytokines, and insulin. J Clin Endocrinol Metab 2008, 93:4276-4281.
9. Roth C.L., Reinehr T., Schernthaner G.H., Kopp H.P., Kriwanek S., Schernthaner G. Ghrelin and obestatin levels in severely obese women before and after weight loss after Roux-en-Y gastric bypass surgery. Obes Surg 2009, 19:29-35.
10. Borg C.M., le Roux C.W., Ghatei M.A., Bloom S.R., Patell A.G., Aylwin S.J.B. Progressive rise in gut hormone levels after Roux-en-Y gastric bypass suggests gut adaptation and explains altered satiety. Br J Surg 2006, 93:210-215.
11. Couce M.E., Cottam D., Esplen J., Scahuer P., Burguera B. Is ghrelin the culprit for weight loss after gastric bypass surgery? A negative answer. Obes Surg 2006, 16:870-878.
12. Mancini M.C., Costa A.P.A.C., Melo M.E., Cercatto C., Gianella-Neto D., Garrido A.B., et al. Effect of gastric bypass on spontaneous growth hormone and ghrelin release profiles. Obesity 2006, 14:383-387.
13. Karamanakos S.N., Vagenas K., Kalfarentzos F., Alexandrides T.K. Weight loss, appetite suppression, and changes in fasting and postprandial ghrelin and peptide-YY levels after Roux-en-Y gastric bypass and sleeve gastrectomy. A prospective, double blind study. Ann Surg 2008, 247:401-407.
14. Liou J.M., Lin J.T., Lee W.J., Wang H.P., Lee Y.C., Chiu H.M., et al. The serial changes of ghrelin and leptin levels and their relations to weight loss after laparoscopic minigastric bypass surgery. Obes Surg 2008, 18:84-89.
15. Oliván B., Teixeira J., Bose M., Bawa B., Chang T., Summe H., et al. Effect of weight loss by diet or gastric bypass surgery on peptide YY3-36 levels. Ann Surg 2009, 249:948-953.
16. Whitson B.A., Leslie D.B., Kellogg T.A., Maddaus M.A., Buchwald H., Billington C.J., et al. Entero-endocrine changes after gastric bypass in diabetic and nondiabetic patients: a preliminary study. J Surg Res 2007, 141:31-39.
17. le Roux C.W., Welbourn R., Werling M., Osborne A., Kokkinos A., Laurenius A., et al. Gut hormones as mediators of appetite and weight loss after Roux-en-Y gastric bypass. Ann Surg 2007, 246:780-785.
18. Korner J., Inabnet W., Conwell I.M., Taveras C., Daud A., Olivero-Rivera L., et al. Differential effects of gastric bypass and banding on circulating gut hormone and leptin levels. Obesity 2006, 14:1553-1561.
19. le Roux C.W., Aylwin S.J.B., Batterham R.L., Borg C.M., Coyle F., Prasad V., et al. Gut hormone profiles following bariatric surgery favor an anoretic state, facilitate weight loss, and improve metabolic parameters. Ann Surg 2006, 243:108-114.
20. Rodieux F., Giusti V., D'Alessio D.A., Suter M., Tappy L. Effects of gastric bypass and gastric banding on glucose kinetics and gut hormone release. Obesity 2008, 16:298-305.
21. Chan J.L., Mun E.C., Stoyneva V., Mantzoros C.S., Goldfine A.B. Peptide YY levels are elevated after gastric bypass surgery. Obesity 2006, 14:194-198.
22. Langer F.B., Reza Hoda M.A., Bohdjalian A., Felberbauer F.X., Zacherl J., Wenzl E., et al. Sleeve gastrectomy and gastric banding: effects on plasma ghrelin levels. Obes Surg 2005, 15:1024-1029.
23. Dixon A.F.R., Dixon J.B., O'Brien P.E. Laparoscopic adjustable gastric banding induces prolonged satiety: a randomized blind crossover study. J Clin Endocrinol Metab 2005, 90:813-819.
24. Uzzan B., Catheline J.M., Lagorce C., Airinei G., Bon C., Cohen R., et al. Expression of ghrelin in fundus is increased after gastric banding in morbidly obese patients. Obes Surg 2007, 17:1159-1164.
25. Carroll J.F., Franks S.F., Smith A.B., Phelps D.R. Visceral adipose tissue loss and insulin resistance 6 months after laparoscopic gastric banding surgery: a preliminary study. Obes Surg 2009, 19:47-55.
26. Ram E., Vishne T., Diker D., Gal-Ad I., Maayan R., Lerner I., et al. Impact of gastric banding on plasma ghrelin, growth hormone, cortisol, DHEA and DHEA-S levels. Obes Surg 2005, 15:1118-1123.
27. Shak J.R., Roper J., Perez-Perez G.I., Tseng C., François F., Gamagaris Z., et al. The effect of laparoscopic gastric banding surgery on plasma levels of appetite-control, insulinotropic, and digestive hormones. Obes Surg 2008, 18:1089-1096.
28. Knerr I., Herzog D., Rauh M., Rascher W., Horbach T. Leptin and ghrelin expression in adipose tissues and serum levels in gastric banding patients. Eur J Clin Invest 2006, 36:389-394.
29. Foschi D., Corsi F., Rizzi A., Asti E., Carsenzuola V., Vago T., et al. Vertical banded gastroplasty modifies plasma ghrelin secretion in obese patients. Obes Surg 2005, 15:1129-1132.
30. Kotidis E.V., Koliakos G.G., Baltzopoulos V.G., Ioannidis K.N., Yovos J.G., Papavramidis S.T. Serum ghrelin, leptin and adiponectin levels before and after weight loss: comparison of three methods of treatment-a prospective study. Obes Surg 2006, 16:1425-1432.
31. Kotidis E.V., Koliakos G.G., Papavramidis T.S., Papavramidis S.T. The effect of biliopancreatic diversion with pylorus-preserving sleeve gastrectomy and duodenal switch on fasting serum ghrelin, leptin and adiponectin levels: is there a hormonal contribution to the weight-reducing effect of this procedure?. Obes Surg 2006, 16:554-559.
32. Stratis C., Alexandrides T., Vagenas K., Kalfarentzos F. Ghrelin and peptide YY levels after a variant of biliopancreatic diversion with Roux-en-Y gastric bypass versus after colectomy: a prospective comparative study. Obes Surg 2006, 16:752-758.
33. Mora M.E.V., Manco M., Capristo E., Guidone C., Iaconelli A., Gniulli D., et al. Growth hormone and ghrelin secretion in severely obese women before and after bariatric surgery. Obesity 2007, 15:2012-2018.
34. Mingrone G., Granato L., Valera-Mora E., Iaconelli A., Calvani M.F., Bracaglia R., et al. Ultradian ghrelin pulsatility is disrupted in morbidly obese subjects after weight loss induced by malabsorptive bariatric surgery. Am J Clin Nutr 2006, 83:1017-1024.
35. Santoro S., Quirilo Milleo F., Malzoni C.E., Klajner S., Borges P.C.M., Santo M.A., et al. Enterohormonal changes after digestive adaptation: five-year results of a surgical proposal to treat obesity and associated diseases. Obes Surg 2008, 18:17-26.
36. Peterli R., Wolnerhanssen B., Peters T., Devaux N., Kern B., Christoffel-Courtin C., et al. Improvement in glucose metabolism after bariatric surgery: comparison of laparoscopic Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy. A prospective randomized trial. Ann Surg 2009, 250:234-241.
37. Christou N.V., Look D., McLean A.P. Pre- and post-prandial plasma ghrelin levels do not correlate with satiety or failure to achieve a successful outcome after Roux-en-Y gastric bypass. Obes Surg 2005, 15:1017-1023.
38. Thaler J.P., Cummings D.E. Minireview: hormonal and metabolic mechanisms of diabetes remission after gastrointestinal surgery. Endocrinology 2009, 150:2518-2525.
39. Williams D.L. Minireview: finding the sweet spot: peripheral versus central glucagon-like peptide 1 action in feeding and glucose homeostasis. Endocrinology 2009, 150:2997-3001.
40. Korner J., Bessler M., Inabnet W., Taveras C., Holst J.J. Exaggerated glucagon-like peptide-1 and blunted glucose-dependent insulinotropic peptide secretion are associated with Roux-en-Y gastric bypass but not adjustable gastric banding. Surg Obes Relat Dis 2007, 3:597-601.
41. Holdstock C., Zethelius B., Sundbom M., Karlsson F.A., Eden Engstrom B. Postprandial changes in gut regulatory peptides in gastric bypass patients. Int J Obes 2008, 32:1640-1646.
42. Vidal J., Nicolau J., Romero F., Casamitjana R., Momblan D., Conget I., et al. Long-term effects of Roux-em-Y gastric bypass on plasma glucagon-like peptide-1 and islet function in morbidly obese subjects. J Clin Endocrinol Metabol 2009, 94:884-891.
43. Guidone C., Manco M., Valera-Mora E., Iaconelli A., Gniuli D., Mari A., et al. Mechanisms of recovery from type 2 diabetes after malabsorptive bariatric surgery. Diabetes 2006, 55:2025-2031.
44. Reinehr T., Roth C.L., Schemthaner G.H., Kopp H.P., Kriwanek S., Schemthaner G. Peptide YY and glucagon-like peptide-1 in morbidly obese patients before and after surgically induced weight loss. Obes Surg 2007, 17:1571-1577.
45. Morínigo R., Lacy A.M., Casamitjana R., Delgado S., Gomis R., Vidal J. GLP-1 and changes in glucose tolerance following gastric bypass surgery in morbidly obese subjects. Obes Surg 2006, 16:1594-1601.
46. Carvalho C.P., Marin D.M., Souza A.L., Pareja L.C., Chaim E.A., Mazon S.B., et al. GLP-1 and adiponectin: effect of weight loss after dietary restriction and gastric bypass in morbidly obese patients with normal and abnormal glucose metabolism. Obes Surg 2009, 19:313-320.
47. Morínigo R., Moize V., Musri M., Lacy A.M., Navarro S., Marin J.L., et al. Glucagon-like peptide-1, peptide YY, hunger, and satiety after gastric bypass surgery in morbidly obese subjects. J Clin Endocrinol Metab 2006, 91:1735-1740.
48. Morínigo R., Vidal J., Lacy A.M., Delgado S., Casamitjana R., Gomis R. Circulating peptide YY, weight loss, and glucose homeostasis after gastric bypass surgery in morbidly obese subjects. Ann Surg 2008, 247:270-275.
49. Laferrère B., Heshka S., Wang K., Khan Y., McGinty J., Teixeira J., et al. Incretin levels and effect are markedly enhanced 1 month after Roux-en-Y gastric bypass surgery in obese patients with type 2 diabetes. Diabetes Care 2007, 30:1709-1716.
50. Salinari S., Bertuzzi A., Asnaghi S., Guidone C., Manco M., Mingrone G. First-phase insulin secretion restoration and differential response to glucose load depending on the route of administration in type 2 diabetic subjects after bariatric surgery. Diabetes Care 2009, 32:375-380.
51. Laferrère B., Teixeira J., McGinty J., Tran H., Egger J.R., Colarusso A., et al. Effect of weight loss by gastric bypass surgery versus hypocaloric diet on glucose and incretin levels in patients with type 2 diabetes. J Clin Endocrinol Metab 2008, 93:2479-2485.
52. Mingrone G., Nolfe G., Gissey G.C., Iaconelli A., Leccesi L., Guidone C., et al. Circadian rhythyms of GIP and GLP1 in glucose-tolerant and type 2 diabetic patients after biliopancreatic diversion. Diabetologia 2009, 52:873-881.
53. Bueter M., le Roux C.W. Sir David Cuthbertson Medal Lecture. Bariatric surgery as a model to study appetite control. Proc Nutr Soc 2009, 68:227-233.
54. Swarbrick M.M., Stanhope K.L., Austrheim-Smith I.T., Van Loan M.D., Ali M.D., Wolfe B.M., et al. Longitudinal changes in pancreatic and adipocyte hormones following Roux-en-Y gastric bypass surgery. Diabetologia 2008, 51:1901-1911.
55. Ernst A., Hellmich S., Bergmann A. Proneurotensin 1-117, a stable neurotensin precursor fragment identified in human circulation. Peptides 2006, 27:1787-1793.
56. Christ-Crain M., Stoeckli R., Ernst A., Morgenthaler N.G., Bilz S., Korbonits M., et al. Effect of gastric bypass and gastric banding on protoneurotensin levels in morbibly obese patients. J Clin Endocrinol Metab 2006, 91:3544-3547.
57. Sjostrom L., Lindroos A.K., Peltonen M., Torgerson J., Bouchard C., Carlsson B., et al. Lifestyle, Diabetes, and Cardiovascular Risk Factors 10 Years after Bariatric Surgery. N Engl J Med 2004, 351:2683-2693.
58. Chandarana K., Drew M.E., Emmanuel J., Karra E., Gelegen C., Chan P., et al. Subject standardization, acclimatization, and sample processing affect gut hormone levels and appetite in humans. Gastroenterology 2009, 136:2115-2126.
59. Fetissov S.O., Sinno M.H., Coeffier M., Bole-Feysot C., Ducrotte P., Hokfelt T., et al. Autoantibodies against appetite-regulating hormones and neuropeptides: putative modulation by gut microbiota. Nutrition 2008, 24:348-359.